"

Active Grants

Statistics for current year research funds

Anthony – Varian,$170,184(TAD)

Burgin – Sound Pharma, $29,304 (TAD)

HalumCellular Reinnervation Therapy for Vocal Fold Paralysis, NIH $543,115 (CYE) $1,916,620 (TAD)

Muscle progenitor cell-based implants for dynamic laryngeal muscle reconstruction, NIH $622,399 (CYE) $2,187,085 (TAD)

Hashino – Engineering High- Fidelity Human Cochlear Organoids, NIH $656,770 (CYE) $1,329,205 (TAD)

Modeling Inner Ear Differentiation with Pluripotent Stem cells, NIH $573,417 (CYE) $3,129,313 (TAD)

Modeling Genetic Inner Ear Disorders with Human Pluripotent Stem Cells, NIH $3,267,128 (TAD)

KoehlerModeling Neurofibromatosis Type 2 with Inner Ear Organoids, NIH $55,194 (CYE) $160,720 (TAD)

Nelson – Mechanisms of Mammalian Genetic Hearing Loss, NIH $613,002 (CYE) $613,002 (TAD)

Mechanisms of Mammalian Genetic Hearing Loss: Diagnostic and Mechanistic Validation of a Metabolic Biomarker Panel to, CTSI Core
$10,000 (CYE) $10,000 (TAD)

O’ConnellGuide Therapeutic Interventions in Friedreich’s Ataxia Virus and olfactory system interactions accelerate Alzheimer’s disease, Ataxia $137,837 (CYE) $274,374 (TAD)

Ramakrishnan –  Pathology UCD $26,081 (CYE) $26,081 (TAD)

Assessing Long-Term Outcomes of DUPIXENT® Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyposis (AROMA), Parexel
$21,460 .72 (CYE) $21,460 .72 (TAD)

ENLIGHTEN 2:A Phase III, Randomized, Blinded, Controlled, Parallel- Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the treatment of Chronic Rhinosinusitis (CRS) in Adults, Medpace $34,006 .64 (CYE) $34,006 .64(TAD)

Scalable 3D molecular imaging and data analysis for cell census generation, ASU $20,521 (CYE) $20,521 (TAD)

Solitary chemosensory cell development and function, NIH $198,125 .00 (CYE) $379,951 .00 (TAD)

CRS Microbiome: Multi-omic Integrative Longitudinal Experimental (CRS-MILE) study, NIH $571,367 .00 (CYE) $571,367 .00(TAD)

SreenathSkull Base Surgery, PuraSinus $47,718 .00 (CYE) $47,718 .00 (TAD)

TottenMechanisms of TMPRSS3-related Hearing Loss, AAO $10,000 (CYE) $10,000 (TAD)

YatesPost-market real-world data collection of the Biodesign® Otologic Repair Graft, Cook Research $10,814 .80 (CYE) $10,814 .80 (TAD)

YuanMolecular mechanisms mediating the soft tissue attachment to teeth, Stanford $38,937 (CYE) $38,937 (TAD)

Role of Wnt-responsive cells in oral mucosa homeostasis, injury, and malignancy, NIH $245,849 (CYE) $794,989 (TAD)

Junctional epithelial stem cells as a therapeutic target for periodontal disease, Showalter Trust $75,000 (CYE) $75,000 (TAD)

Zhao – Cellular Reinnervation Therapy for Vocal Fold Paralysis, NIH $543,115 (CYE) $1,916,620 (TAD)

Muscle progenitor cell-based implants for dynamic laryngeal muscle reconstruction, NIH $622,399 (CYE) $2,187,085 (TAD)

Cellular Reinnervation Therapy for Vocal Fold Paralysis, NIH $543,115 (CYE) $1,916,620 (TAD)

Muscle progenitor cell-based implants for dynamic laryngeal muscle reconstruction, NIH $622,399 (CYE) $2,187,085 (TAD)

License

Department of Otolaryngology 2023 Annual Report Copyright © by Cindy Dance. All Rights Reserved.